Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways

Yan, XJ; Yu, HY; Liang, JL; Hu, ZY; Li, XJ; Liu, HY; Yao, J; Sui, X; Zheng, J; Li, R

Zheng, J (通讯作者)，Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, Guangzhou 510630, Peoples R China.;Zheng, J (通讯作者)，Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Guangzhou 510630, Peoples R China.;Li, R (通讯作者)，Sun Yat Sen Univ, Affiliated Hosp 3, Guangdong Prov Key Lab Liver Dis Res, Guangzhou 510630, Peoples R China.;Sui, X (通讯作者)，Sun Yat Sen Univ, Surg ICU, Affiliated Hosp 3, Guangzhou 510630, Peoples R China.

CELL DEATH DISCOVERY, 2023; 9 (1):

Abstract

It has been established that monotherapy yields limited efficacy in treating hepatocellular carcinoma (HCC), especially advanced HCC. Increasing evide......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索